Cite
HARVARD Citation
Pearson, S. et al. (2018). Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements. Therapeutic advances in endocrinology and metabolism. pp. 113-121. [Online].